Table 1. Q3 2021 Corporate Quarterly Updates: Small and Mid-Cap Biotech

Table 1. Ticker, drug, and indication for biopharma companies with current (10/08/21) market cap under $5B that receive revenue from approved drugs thuough their or their partners commercialization efforts